))
Dr. Amy LeBlanc | Pets Paving Progress in Research
Manage episode 421543451 series 3561919
Sisällön tarjoaa ImpriMed, Inc.. ImpriMed, Inc. tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.
In this enlightening episode of the Veterinary Cancer Pioneers Podcast, host Dr. Rachel Venable speaks with Dr. Amy LeBlanc, a Senior Scientist and Director at the National Institute of Health's CCR Comparative Oncology Program. Dr. LeBlanc discusses the compelling integration of canine models into cancer research, emphasizing the translational benefits that dogs offer in understanding and treating human cancers. She highlights her team's work with naturally occurring cancers in pets, aiming to improve treatment options for both human and veterinary patients. The episode delves into the challenges and innovations in comparative oncology, showcasing how dogs, sharing our environments and cancers similar to humans, provide a unique bridge in cancer research that could lead to breakthrough therapies.
📝Transcripts are available at https://www.imprimedicine.com/podcast.
To learn more about ImpriMed Personalized Prediction Profile, please visit https://www.imprimedicine.com/personalized-prediction-profile
Music Credit: Hazy by Beat Mekanik
19 jaksoa
Jaa
